Evidence map›Paper›PMID 40498504›Full record

SynthesisJAMA dermatology2025

Retrieval Augmented Generation-Enabled Large Language Model for Risk Stratification of Cutaneous Squamous Cell Carcinoma.

Neil K Jairath, Vartan Pahalyants, Shayan Cheraghlou, Derek Maas, Nayoung Lee, Maressa C Criscito, Mary L Stevenson, Apoorva Mehta, Zachary Leibovit-Reiben, Alyssa Stockard and 3 more

Abstract readSystematic Review
In one paragraph

Synthesis in JAMA dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Neil K JairathThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Vartan PahalyantsThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Shayan CheraghlouThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Derek MaasThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Nayoung LeeThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Maressa C CriscitoThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Mary L StevensonThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Apoorva MehtaThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Zachary Leibovit-ReibenDepartment of Dermatology, Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona.
Alyssa StockardDepartment of Dermatology, Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona.
Nicole DoudicanThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.
Aaron MangoldDepartment of Dermatology, Mayo Clinic Comprehensive Cancer Center, Phoenix, Arizona.
John A CarucciThe Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York.

Funding

SHORT-TERM TRAINING STUDENTS IN HEALTH PROFESSIONAL SCHOT35HL007479 · NHLBI · UNIVERSITY OF ARIZONA · PI GEOFFREY C GURTNER, JAMES Kuang-Jan LIAO · 1985 to 2026
$4.4M
NHLBI NIH HHS T35 HL007479
6 · The paper itself

Abstract

Importance: There exists substantial heterogeneity in outcomes within T stages for patients with cutaneous squamous cell carcinoma (cSCC). Objective: To determine whether a customized generative pretrained transformer model, trained on a comprehensive dataset with more than 1 trillion parameters and equipped with relevant focused context and retrieval augmented generation (RAG), could excel in aggregating and interpreting vast quantities of data to develop a novel class-based risk stratification system that outperforms the current standards. Design, Setting, and Participants: To build the RAG knowledge base, a systematic review of the literature was conducted that addressed risk factors for poor outcomes in cSCC. Using the RAG-enabled generative pretrained transformer (GPT) model, we developed a novel class-based risk stratification system that assigned point values for risk factors, culminating in a GPT-based prognostication system called the artificial intelligence-derived risk score (AIRIS). The system's performance was validated on a combined prospective and retrospective cohort of 2379 primary cSCC tumors (1996-2023) with at least 36 months of follow-up, against Brigham and Women's Hospital (BWH) and American Joint Committee on Cancer Staging Manual, eighth edition (AJCC8) systems in stratifying risk for locoregional recurrence (LR), nodal metastasis (NM), distant metastasis (DM), and disease-specific death (DSD). Main Outcomes and Measures: Performance metrics evaluated included distinctiveness, homogeneity, and monotonicity, as defined by the AJCC8, as well as sensitivity, specificity, positive predictive value, negative predictive value, accuracy, the area under the receiver operating characteristic curve, and concordance. Results: The median age at diagnosis was 73 (IQR, 64-81) years, with 38.5% female patients and 61.5% male patients. The AIRIS prognostication system demonstrated superior sensitivity across all outcomes (LR, 49.1%; NM, 73.7%; DM, 82.5%; and DSD, 72.2%) and the highest area under the receiver operating characteristic curve values (LR, 0.69; NM, 0.81; DM, 0.85; and DSD, 0.80), indicating significantly enhanced discriminative capability compared with the BWH and AJCC8 systems. While all systems were comparably distinctive, the AIRIS prognostication system consistently demonstrated the lowest proportion of tumors exhibiting poor outcomes in low-risk categories, suggesting its improved homogeneity and monotonicity. Conclusions and Relevance: The results of this diagnostic study suggest that the AIRIS system outperforms the existing BWH and AJCC8 prognostication systems, potentially providing a more effective tool for predicting poor outcomes in cSCC. This study illustrates the potential of large language models in refining prognostic tools, offering implications for treating patients with cancer.

Indexed as

Artificial IntelligenceCarcinoma, Squamous CellSkin NeoplasmsAgedFemaleHumansLarge Language ModelsMaleMiddle AgedNeoplasm StagingPrognosisProspective StudiesRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID40498504
PMCPMC12159850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.